The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "AI in Biotechnology Market - Global Industry Size, Share, Growth, Trends, Opportunity, and Forecast, 2025-2033" report has been added to ...
DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...
The company's earnings totaled $79.37 million, or $2.66 per share. This compares with $27.18 million, or $0.91 per share, last year. The company's revenue for the period rose 16.7% to $97.80 million ...
Few neighborhoods in Cambridge have seen their fortunes change as dramatically as Kendall Square. Kendall was once known for churning out soap and vulcanized rubber, then manufacturing electronics as ...
With a newly marketed product in Japan and 10 years of clinical data, regenerative cell therapies promise new options for patients facing a choice between invasive surgery or blindness. Analogs of the ...
(RTTNews) - IO Biotech (IOBT), a clinical-stage biopharmaceutical company focused on cancer vaccines, Monday reported positive phase 3 results for Cylembio, in combination with Merck & Co Inc.'s (MRK) ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The collaboration aims to ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. The Food and Drug ...
Bioscience Los Angeles County Inc. CEO Steph Hsieh knows that biotech is the future for LA — the industry is a huge employer and it is among the fastest growing in the country. Many jobs in the ...
New York Mets owner and billionaire investor Steven Cohen is known for a high-risk/reward investing approach. He founded the now-defunct SAC Capital Advisors, which was among the most successful hedge ...
MAIA Biotechnology (MAIA) announced highlights from a recent presentation at the European Society for Medical Oncology, ESMO, Congress 2025 held in Berlin, Germany. Starting October 19, 2025, MAIA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback